admin, Author at PsyNews.com

Home Authors Posts by admin

2176 POSTS 0 COMMENTS

https://psynews.com

Numinus Announces Key Milestones in MAPS-Sponsored MDMA-Assisted Therapy for PTSD Clinical...

Two thirds of physicians surveyed believe psilocybin therapy has potential benefit...

Psygen Receives Dealer’s Licence from Health Canada

Red Light Holland to Collaborate with Advocacy Group, Psychedelic Medicine Alliance...

Optimi Health Submits Natural Psilocybin Combined Drug Delivery and Extraction Formulations...

Entheon Biomedical Subsidiary, HaluGen Life Sciences, Announces Agreement with Psychedelics Today

BetterLife Obtains Positive In Vivo Oral Bioavailability, Food Effect and Pharmacokinetics...

Entheon Biomedical Corp. Files Preliminary Shelf Prospectus

Mydecine Signs LOI with The Newly Institute to Provide Psychedelic-Assisted Psychotherapy...

MindMed Enrolls First Participant in a Study of its Session Monitoring...

1...164165166...218 Page 165 of 218

The Interdisciplinary Annotated Psychedelic Research Bibliography of 2024

Reflections on the 2025 Federal Policy Summit on Psychedelic Medicine

Spring 2025 Psychedelic Policy Update: Bills Hang in the Balance as...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

admin